Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.44 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | RARA | P10276 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25394857 | 1.00 | NPC1 (0.47) | NPC1RAB9AEGFRMKNK1MKNK2 | |
| SCHEMBL25395879 | 1.00 | NPC1 (0.47) | NPC1RAB9AEGFRMKNK1MKNK2 | |
| SCHEMBL3475755 | 0.95 | TSHR (0.44) | NPC1RAB9AMKNK1MKNK2KDM4E | |
| SCHEMBL21768343 | 0.93 | TP53 (0.43) | NPC1RAB9AMKNK1MKNK2KDM4E | |
| SCHEMBL17183610 | 0.93 | TP53 (0.43) | NPC1RAB9AMKNK1MKNK2KDM4E | |
| SCHEMBL22463700 | 0.89 | CA2 (0.52) | RAB9AEGFRMKNK1MKNK2TSHR | |
| SCHEMBL1977054 | 0.87 | ALDH1A1 (0.53) | NPC1RAB9AKDM4ESMN1; SMN2TSHR | |
| SCHEMBL27814178 | 0.87 | MKNK1 (0.50) | NPC1RAB9AMKNK1MKNK2KDM4E | |
| SCHEMBL29163406 | 0.87 | NPC1 (0.38) | NPC1RAB9AEGFRMKNK1MKNK2 | |
| SCHEMBL29163495 | 0.85 | NPC1 (0.37) | NPC1RAB9AEGFRMKNK1MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117482993-A | Method for preparing hydrogen peroxide based on amorphous porphyrin supermolecule photocatalyst | 江南大学 | 2024-02-02 | — | — | CN | claimed |
| CN-113218921-B | Fluorescence ratio sensor for detecting heavy metals | 江门职业技术学院 | 2022-08-12 | — | — | CN | claimed |
| CN-112940268-B | Interface in-situ growth metal-organic framework material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2022-04-12 | — | — | CN | claimed |
| CN-113218921-A | Fluorescence ratio sensor for detecting heavy metals | 江门职业技术学院 | 2021-08-06 | — | — | CN | claimed |
| CN-113109304-A | Recyclable and reusable fluorescent sensor and preparation method thereof | 江门职业技术学院 | 2021-07-13 | — | — | CN | claimed |
| CN-113092423-A | Solid-state fluorescence sensor, preparation method thereof and application thereof in metal ion detection | 江门职业技术学院 | 2021-07-09 | — | — | CN | claimed |
| CN-112940268-A | Interface in-situ growth metal-organic framework material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2021-06-11 | — | — | CN | claimed |
| US-9581594-B2 | Porphyrin—modified antimicrobial peptides for application as indicators of microbial targets | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2017-02-28 | — | — | US | claimed |
| WO-2014159904-A1 | PORPHYRIN-MODIFIED ANTIMICROBIAL PEPTIDES FOR APPLICATION AS INDICATORS OF MICROBIAL TARGETS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2014-10-02 | — | — | WO | claimed |
| US-20140274776-A1 | Porphyrin-Modified Antimicrobial Peptides for Application as Indicators of Microbial Targets | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2014-09-18 | — | — | US | claimed |
| EP-1494694-B1 | Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging | DEVELOGEN ISRAEL LTD (IL) | 2013-05-08 | — | — | EP | claimed |
| US-7700717-B2 | Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging | DEVELOGEN ISRAEL LTD. (IL) | 2010-04-20 | — | — | US | claimed |
| US-20050090429-A1 | Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging | TEL HASHOMER - MEDICAL RESEARCH, INFRASTRUCTURE AND SERVICES LTD. (IL) | 2005-04-28 | — | — | US | claimed |
| US-20250034027-A1 | METHOD FOR PREPARING GLASS NANOSTRUCTURES AND NANOSTRUCTURED SUBSTRATES THEREOF | CORNING INCORPORATED | 2025-01-30 | — | — | US | disclosed |
| CN-111433320-B | Quantum dot, method for producing same, resin composition, wavelength conversion material, and light-emitting element | 信越化学工业株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-117482993-A | Method for preparing hydrogen peroxide based on amorphous porphyrin supermolecule photocatalyst | 江南大学 | 2024-02-02 | — | — | CN | disclosed |
| EP-2412677-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | National University Corporation Okayama University (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-7700717-B2 | Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging | DEVELOGEN ISRAEL LTD. (IL) | 2010-04-20 | — | — | US | disclosed |
| US-20050090429-A1 | Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging | TEL HASHOMER - MEDICAL RESEARCH, INFRASTRUCTURE AND SERVICES LTD. (IL) | 2005-04-28 | — | — | US | disclosed |
| WO-2004092185-A1 | LUMINESCENT LANTHANIDE (III) -CHELATED DENDRITIC COMPLEXES HAVING LIGHT-HARVESTING EFFECT AND THEIR SYNTHETIC METHODS | KIM HWAN-KYU (KR) | 2004-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090429-A1 | Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging | SSTR4, SSTR1, SSTR3 | NPC1 2870/4885RAB9A 3331/4885EGFR 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.